A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an Example

BACKGROUND: Data on absolute risks of outcomes and patterns of drug use in cost-effectiveness analyses are often based on randomised clinical trials (RCTs). The objective of this study was to evaluate the external validity of published cost-effectiveness studies by comparing the data used in these s...

Descripción completa

Detalles Bibliográficos
Autores principales: van Staa, Tjeerd-Pieter, Leufkens, Hubert G., Zhang, Bill, Smeeth, Liam
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779340/
https://www.ncbi.nlm.nih.gov/pubmed/19997499
http://dx.doi.org/10.1371/journal.pmed.1000194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779340/
https://www.ncbi.nlm.nih.gov/pubmed/19997499
http://dx.doi.org/10.1371/journal.pmed.1000194

Ejemplares similares